You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

12-200

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in Tatuí (Flamboyant 200/12, Budesonide / Formoterol 400/12, Flamboyant 200/12 Placebo)

Recruiting
  • Asthma
  • Flamboyant 200/12
  • +3 more
  • Tatuí, São Paulo, Brazil
    IMC Tatuí
Jul 25, 2022

Asthma Trial in Porto Alegre, Tatuí, São Paulo (Flamboyant 125/12, Budesonide/formoterol 200/6, Flamboyant 125/12 Placebo)

Recruiting
  • Asthma
  • Flamboyant 125/12
  • +3 more
  • Porto Alegre, Rio Grande Do Sul, Brazil
  • +2 more
Jul 25, 2022

Lung Non-Small Cell Carcinoma Trial in Buffalo (Pembrolizumab)

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • Pembrolizumab
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 27, 2023

Asthma Copd Trial (Alenia® 12mcg + 400mcg / Alenia® 6mcg + 200mcg)

Not yet recruiting
  • Asthma Copd
  • Alenia® 12mcg + 400mcg / Alenia® 6mcg + 200mcg
  • São Paulo, Brazil
    Eurofarma Laboratorios S.A
Nov 29, 2022

Osteoarthritis of the Knee Trial (Etoricoxib 30 mg, Celecoxib 200 mg)

Completed
Has Results
  • Osteoarthritis of the Knee
  • Etoricoxib 30 mg
  • Celecoxib 200 mg
  • (no location specified)
Feb 7, 2022

Asthma Trial in Edegem (Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI, Reference product 1 (R1): CHF 5993 BDP/FF/GB

Recruiting
  • Asthma
  • Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI
  • +2 more
  • Edegem, Antwerpen, Belgium
    SGS Belgium NV - Clinical Pharmacology Unit
Jun 1, 2023

Rheumatoid Arthritis (RA), Inflammatory Bowel Disease - IBD1 Trial in Guizhou (ZL-82 12.5mg, ZL-82 25mg, ZL-82 50mg)

Recruiting
  • Rheumatoid Arthritis (RA)
  • Inflammatory Bowel Disease - IBD1
  • ZL-82 12.5mg
  • +7 more
  • Guizhou, GuiYang, China
    Affiliated Hospital of Guizhou Medical University
Sep 19, 2023

Atopic Dermatitis Trial in India (Abrocitinib 100 mg, Abrocitinib 200 mg)

Recruiting
  • Atopic Dermatitis
  • Abrocitinib 100 mg
  • Abrocitinib 200 mg
  • New Delhi, Delhi, India
  • +14 more
Jan 9, 2023

Asthma Trial in Pisa (CHF1535 200/6 µg, BDP 100 µg)

Completed
  • Asthma
  • CHF1535 200/6 µg
  • BDP 100 µg
  • Pisa, Italy
    Cardio-Thoracic and Vascular Dept, University of Pisa
Oct 28, 2021

Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)

Recruiting
  • Axial Spondyloarthritis
  • Tapered doses of TNFi
  • Standard dose of TNFi
  • Toronto, Ontario, Canada
    University Health Network - Toronto Western Hospital
Nov 21, 2022

Chronic Periodontitis Trial in Daejeon (ALH-L1005 600mg/day, ALH-L1005 1,200mg/day, Placebo)

Completed
  • Chronic Periodontitis
  • ALH-L1005 600mg/day
  • +2 more
  • Daejeon, Daejeon Gwangyeogsi, Korea, Republic of
    AngioLab, Inc.
Aug 9, 2022

Non-Small-Cell Lung Carcinoma Trial (biological, drug, dietary supplement)

Active, not recruiting
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Pembrolizumab 200 mg
  • +7 more
  • (no location specified)
Aug 16, 2022

COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)

Completed
  • COPD
  • CHF 1535 NEXThaler 800/48
  • +4 more
  • Manchester, United Kingdom
    Medicine Evaluation Unit
Oct 28, 2021

Septic Shock Trial in Milwaukee (Hydroxocobalamin, Placebo)

Recruiting
  • Septic Shock
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Nov 30, 2021

Hepatitis C Trial in Alor Star (Sofosbuvir 400 MG, Ravidasvir 200mg)

Recruiting
  • Hepatitis C
  • Sofosbuvir 400 MG
  • Ravidasvir 200mg
  • Alor Star, Kedah, Malaysia
    Hospital Sultanah Bahiyah
May 17, 2021

ADHD Trial in United States (HLD200 methylphenidate HCl (MPH) Capsules, Placebo)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • HLD200 methylphenidate hydrochloride (MPH) Capsules
  • Placebo
  • Newport Beach, California
  • +6 more
Jul 1, 2021

COVID-19 Trial in South Africa (Molnupiravir 200 mg)

Recruiting
  • COVID-19
  • Molnupiravir 200 mg
  • Umtata, Eastern Cape, South Africa
  • +3 more
Aug 12, 2022

Non-Small-Cell Lung Carcinoma Trial in Japan (biological, drug, dietary supplement)

Active, not recruiting
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Pembrolizumab 200 mg
  • +7 more
  • Nagoya, Aichi, Japan
  • +9 more
Jan 23, 2023

COPD Trial in Paris (Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI, Budesonide 200 µg plus formoterol 6 µg DPI,

Completed
  • Chronic Obstructive Pulmonary Disease
  • Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI
  • +2 more
  • Paris, France
    Thomas Similowski
Oct 28, 2021

Sleep Apnea Syndromes, Sleep Disorder, Sleep Trial in Aurora (WatchPAT Intervention)

Completed
Has Results
  • Sleep Apnea Syndromes
  • +2 more
  • WatchPAT Intervention
  • Aurora, Colorado
    Children's Hospital Colorado
Apr 20, 2021

Primary and Secondary Ventral Hernia Trial in Worldwide (Placing the resorbable mesh, Non-resorbable synthetic mesh.)

Active, not recruiting
  • Primary and Secondary Ventral Hernia
  • Placing the resorbable mesh
  • Non-resorbable synthetic mesh.
  • Ghent, Belgium
  • +5 more
Aug 27, 2021

Respiratory Syncytial Virus Trial in Worldwide (Ad26.RSV.preF, Placebo, Nimenrix)

Completed
  • Respiratory Syncytial Virus
  • Ad26.RSV.preF
  • +2 more
  • Geelong, Australia
  • +24 more
Nov 23, 2021

Urinary Bladder Tumors Trial in Worldwide (TAR-200, Cetrelimab)

Recruiting
  • Urinary Bladder Neoplasms
  • Birmingham, Alabama
  • +118 more
Jan 27, 2023

ADHD Trial in United States (HLD200 methylphenidate HCl (MPH) Capsules, Placebo)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • HLD200 methylphenidate hydrochloride (MPH) Capsules
  • Placebo
  • Newport Beach, California
  • +20 more
Jul 1, 2021

Covid19, Corona Virus Infection Trial in Worldwide (Baricitinib)

Recruiting
  • Covid19
  • Corona Virus Infection
  • Orlando, Florida
  • +20 more
Jan 18, 2023